OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allostery: The Good, the Bad, and the Ugly
Terry Kenakin
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 1, pp. 110-120
Open Access | Times Cited: 6

Showing 6 citing articles:

Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition
Terry Kenakin
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 626-644
Closed Access | Times Cited: 8

Long COVID – a critical disruption of cholinergic neurotransmission?
Marco Leitzke, Donald Troy Roach, Swen Hesse, et al.
Bioelectronic Medicine (2025) Vol. 11, Iss. 1
Open Access

Allostery in Disease: Anticancer Drugs, Pockets, and the Tumor Heterogeneity Challenge
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Journal of Molecular Biology (2025), pp. 169050-169050
Open Access

The cannabinoid CB 2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Journal of Receptors and Signal Transduction (2024), pp. 1-9
Closed Access | Times Cited: 1

Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators
Janko Kos, Monica Langiu, Shane D. Hellyer, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3671-3690
Open Access

Dusting off old blueprints: Is it time to reconsider metabotropic glutamate receptor 2 for therapeutic drug development?
Anton Bespalov, Robert Lütjens, Darı́o Doller
Pharmacology Biochemistry and Behavior (2024) Vol. 247, pp. 173908-173908
Closed Access

Page 1

Scroll to top